Summary

Overview
Global Histology and Cytology Consumables Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
Histology consumables improve quality, reduce errors, and save time with dedicated plug-and-play consumables. From glass slides and coverslips to wax and bulk reagents, the smooth running of any laboratory depends on a consistent supply of high-quality consumables. Whereas Cytology is the branch of biology dealing with the morphology, structure, ultrastructure, life cycle, and pathology of cells. Historically cytology has referred to the study of the microscopic appearance of cells and cell structures, especially for the diagnosis of abnormalities and malignancies.
Market Dynamics: Drivers and Restraints
Strategies adopted by the key companies
The key companies have increased their investments, expansion, collaborations and partnerships in the release of novel anatomical pathology consumables to meet the most demanding demands of contemporary histology laboratories.
For instance, in July 2023, StatLab Medical Products, a McKinney-based developer and manufacturer of medical diagnostic supplies, launched a new manufacturing facility in Arlington after acquiring two UK-based histology consumables and diagnostic equipment companies in 2021 and 2022. Injection molding operations at the new 35,000-square-foot Arlington facility will give laboratories confidence in additional U.S.-produced core histology consumables including cassettes.
In the future company plans to launch of archiving service that not only will cement StatLab as a market leader in the histology consumables market, but also provide laboratories with a comprehensive off-site solution for sample archiving, allowing them to be stored and retrieved when needed, saving valuable time and storage space.
Furthermore, increased demand for research and development for early disease detection and diagnosis, increased healthcare spending. An increase in hospitals and diagnostic laboratories, and increased demand for personalized medicines necessitates the study of individual cell structure and function, an increase in the prevalence of cell-based diseases such as cancer and autoimmune diseases requires the detection and diagnosis of specific cells and tissue.
Market Dynamics: Restraint
The stringent government regulations policies and complicated procedures associated with histology and cytology are the factors that are expected to hinder growth of the global histology and cytology market over the forecast period. For instance, according to an article published by the National Center for Biotechnology Information (NCBI) in May 2021, histological specimen slide preparation involves a number of steps such as fixation, dehydration, embedding, sectioning, and others which can prove to be a complicated and time-consuming task.
For more details of the report- Request for sample
Segment Analysis
The global histology and cytology consumables market is segmented based on product type, application, end-user and region.
The histology and cytology stains and dyes segment from the product type segment accounted for approximately 43.5% of the histology and cytology consumables market share
The triple histology and cytology consumables segment from the product type segment accounted for approximately 43.5% and is expected to be dominated during the forecast period. Several consumables are used for the histology and cytology process such as tissue sample containers, kits, stain reagents, fixative solutions, medium reagents, and other reagents. The large share of the segment can be primarily attributed to the routine adoption of histology and cytology consumables.
For instance, in March 2020, ELITechGroup Inc., recognized worldwide as slide staining and cytocentrifuge technologic pioneers and innovators, with nearly 30 patents, over the 35-year lifespan of Aerospray staining technology, stated the launch of the Aerospray Cytology Slide Stainer Cytocentrifuge.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the factors like high incidences of cancer, FDA clearance, extensive R&D activities, presence of key players, and established research infrastructure for pathology services. In addition, the high rate of product approval and commercialization in the region is further contributing to the growth of the market for histology and cytology.
For instance, in April 2023, Danaher’s Leica Biosystems announced the U.S. FDA clearance for its Bond MMR Antibody Panel, which offers a high-performing immunohistochemistry (IHC) mismatch repair (MMR) opportunity for clients that are screening colorectal cancer (CRC) individuals for probable Lynch syndrome. The various launches for efficient screening of tissues and cells for diagnostic purposes.
Moreover, in April 2021, Sakura Finetek USA, Inc. stated the launch of the Tissue-Tek Histology Reagents, delivering a full complement of consistent, reliable and high-quality reagents to meet the tissue fixation, processing, and staining needs of histology laboratories.
“The new line of Tissue-Tek Histology Reagents completes our product portfolio of consumables for use on our Tissue-Tek VIP Series of tissue processors and Tissue-Tek Prisma Series automated slide staining systems.
COVID-19 Impact Analysis
The COVID-19 pandemic had a positive impact on the growth of the market for histology and cytology. Various strategic collaborations were observed between the companies for developing antibodies specific for validation with immunohistochemistry. For instance, in September 2020, GeneTex, Inc. partnered with HistoWiz, Inc. to establish various validated antibodies for immunohistochemistry in human COVID-19-infected tissues.
Market Segmentation
By Product Type
• Histology and Cytology Stains and Dyes
• Histology and Cytology Kits and Reagents
• Histology and Cytology Enzymes
• Others
By Application
• Molecular Diagnostics
• Cell Signaling
• Clinical Diagnosis
• Epigenetics and Sequencing Study
• Others
By End User
• Hospitals
• Diagnostic Centers
• Academic Research Institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Thermo Fisher Scientific, Inc., Leica Biosystems, Becton Dickinson and Company., Hoffmann-La Roche Ltd., Hologics, Merck, Trivitron Healthcare, Cardinal Health, Hospitex International Srl, CellPath and among others.
Key Developments
 In February 2023, BioReference Health LLC announced it would be one of the first commercial laboratories to offer the CINtec PLUS Cytology test from Roche Diagnostics. CINtec PLUS Cytology is the only FDA-approved dual-stain triage test for patients who have a positive high-risk human papillomavirus (HPV) result.
 In December 2022, Labcorp a leading global life sciences company, announced that it has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in Los Angeles, expanding the company’s global central laboratory capabilities.
 In July 2022, Nanostics Inc. launched a prospective clinical study to validate a novel and minimally invasive bladder cancer diagnostic test, Clarity DX Bladder, using its Clarity DX diagnostic platform.
Why Purchase the Report?
• To visualize the global histology and cytology consumables market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of histology and cytology consumables market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global histology and cytology consumables market report would provide approximately 77 tables, 79 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Strategies adopted by the key companies
4.1.1.2. Rise in the prevalence of chronic diseases
4.1.2. Restraints
4.1.2.1. Stringent government regulations policies
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Histology and Cytology Stains and Dyes*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Histology and Cytology Enzymes
7.4. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Molecular Diagnostics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cell Signaling
8.4. Clinical Diagnosis
8.5. Epigenetics and Sequencing Study
8.6. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostic Centers
9.4. Academic Research Institutes
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.5.1. China
10.5.5.2. India
10.5.5.3. Japan
10.5.5.4. Australia
10.5.5.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Thermo Fisher Scientific, Inc*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Leica Biosystems
12.3. Becton Dickinson and Company.
12.4. Hoffmann-La Roche Ltd.
12.5. Hologics
12.6. Merck
12.7. Trivitron Healthcare
12.8. Cardinal Health
12.9. Hospitex International Srl
12.10. CellPath
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us